Likacin

Amikacin, the active ingredient in Likacin, is an aminoglycoside antibiotic presented as a topical formulation for cutaneous use. It is employed to treat bacterial skin and soft‑tissue infections caused by susceptible Gram‑negative organisms.

GNH USA supplies Likacin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Our distribution network ensures timely delivery and reliable support for healthcare providers seeking reliable antibacterial solutions.

Likacin is a topical aminoglycoside used to manage bacterial skin and soft‑tissue infections.

Complicated skin and soft‑tissue infections: reduces bacterial load and promotes healing. Burn wound infections: eradicates Gram‑negative pathogens from burn areas. Post‑surgical wound infections: prevents colonisation by susceptible bacteria. Diabetic foot ulcers: helps control infection in chronic ulcerative lesions. Traumatic skin abrasions: limits bacterial proliferation and reduces risk of secondary infection.

Topical application of amikacin may be associated with local and systemic adverse reactions.

Common Side Effects: - Local irritation: redness or burning at the application site. - Pruritus: itching around the treated area. - Dermatitis: mild rash or eczema‑like eruption. - Pain: discomfort or tenderness at the site.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe skin reaction with swelling and vesicles. - Systemic nephrotoxicity: impaired kidney function if absorbed over large areas. - Ototoxicity: hearing loss or balance disturbances in rare cases of systemic exposure.

When using Likacin, healthcare professionals should observe several precautionary measures to minimise risks. - Renal function: assess baseline kidney status and monitor if extensive skin areas are treated. - Hearing: evaluate auditory function in patients with pre‑existing ear disorders. - Pregnancy and lactation: prescribe only when benefit outweighs potential risk to fetus or infant. - Allergy: avoid use in individuals with known hypersensitivity to amikacin or other aminoglycosides. - Resistance: limit application to infections confirmed to be caused by susceptible organisms to prevent resistance development. - Store at room temperature: keep in original container, protect from moisture and light.

Amikacin may interact with other medicines, altering its safety profile or efficacy.

Major Interactions (Avoid): - Nephrotoxic agents (e.g., vancomycin, amphotericin B, loop diuretics): increased risk of kidney injury. - Ototoxic drugs (e.g., gentamicin, streptomycin, furosemide): heightened potential for hearing loss. - Neuromuscular blocking agents (e.g., succinylcholine, pancuronium): may potentiate muscle weakness.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may modestly affect renal clearance of amikacin. - Other aminoglycosides: concurrent use can increase cumulative toxicity. - Diuretics: monitor electrolytes and renal function during combined therapy.